Evidence map›Paper›PMID 33053982›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Effect of aspirin on hepatocellular carcinoma and its related mechanism].

Y W Liu, H Q Xu, Q Zhou, J Q Niu

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Y W LiuDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, China.
H Q XuDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, China.
Q ZhouDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, China.
J Q NiuDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, China.
Jilin University · CN

Funding

National Key Basic Research Development Program 2015CB554304
6 · The paper itself

Abstract

Aspirin, as a traditional non-steroidal anti-inflammatory drug, has therapeutic and preventive effects on gastrointestinal tumors. Hepatocellular carcinoma is one of the most common malignant tumors in the digestive tract, so it is necessary to find effective preventive and therapeutic measures. This article reviews the research progress and mechanism of aspirin on hepatocellular carcinoma with a view to provide references for future clinical treatment.

Indexed as

Carcinoma, HepatocellularGastrointestinal NeoplasmsLiver NeoplasmsAnti-Inflammatory Agents, Non-SteroidalAspirinHumansAnti-Inflammatory Agents, Non-SteroidalAspirinAspirinHepatocellular carcinomaMechanism

Identifiers

PMID33053982
PMCPMC12769268
OpenAlexW3092804608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.